Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Bristol-Myers Squibb patents NS5B inhibitors

April 21, 2016

Elbasvir and grazoprevir granted priority review in Japan

April 20, 2016

Arbutus Biopharma presents novel small-molecule inhibitor of HBV capsid assembly

April 20, 2016

BARDA awards contract to Basilea for phase III development of ceftobiprole

April 20, 2016

Assembly Biosciences discloses novel CpAM candidate

April 20, 2016

Protein Sciences, Sinergium Biotech and the Mundo Sano collaborate on Zika vaccine

April 20, 2016

GeoVax gives update on its Zika vaccine program

April 20, 2016

Novel antibacterial agent shows in vitro efficacy

April 19, 2016

RedHill plans confirmatory phase III study for RHB-105

April 19, 2016

WHO advisory group recommends use of Dengvaxia in endemic countries

April 18, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 12, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...